Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

multiple dose bioequivalence study [Design Issues]

posted by Loky do – Egypt, 2020-08-09 13:50 (1497 d 08:16 ago) – Posting: # 21842
Views: 3,198

Dears

If we have solifenacin 6 mg (immediate-release) / tamsulosin 0.4 mg modified-release product combination, is multiple-dose bioequivalence study required to be submitted to the European authorities in addition to fast & fed studies, as there is no specific guidance for this product & in GCC region fast & fed studies only accepted.

Thanks in advance

Complete thread:

multiple dose bioequivalence studyLoky do 2020-08-09 11:50 [Design Issues]
- EMA MR: long half life → MD Helmut 2020-08-09 12:08
  - EMA MR: long half life → MD Loky do 2020-08-09 19:06
- multiple dose bioequivalence study wienui 2020-08-10 08:00

Admin contact
23,224 posts in 4,878 threads, 1,652 registered users;
43 visitors (0 registered, 43 guests [including 9 identified bots]).
Forum time: 22:07 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz